The stream · 141 published

Research analysis

Every day this stream takes new work from the research library, papers, preprints, grants and trials, and asks one question of each: what does this change for organoid models of human organs and the drug-discovery work built on them? Written to be useful to a working scientist and legible to a careful newcomer.

Rows of culture plates under a robotic liquid-handling arm in cool blue light.
Each analysis reads one new result for what it changes about the models and the assays built on them. Illustration.

Every analysis, newest first

August 26, 2026 LINC hydrogels for organoid and assembloid manufacturing
NSF award 2427971 supports LINC hydrogels, tunable biomaterials built from biocompatible polymers crosslinked by self-assembled lipid vesicles, for intestinal, neural, and glioma organoids.
August 26, 2026 Microbial control of intestinal organoids for drug absorption
NSF award 2240045 supports microfluidic devices that incorporate anaerobic gut bacteria into intestinal organoids, aiming to reduce variability in oral small-molecule drug absorption models.
August 26, 2026 Organoid-guided therapy for advanced solid tumors enters phase II
NCT06077591 is a single-center 40-patient phase II trial testing next-generation sequencing plus patient-derived tumor organoid drug screens to guide therapy in advanced or inoperable solid tumors, mainly hepatocellular carcinoma and colorectal cancer.
August 25, 2026 Organoid-guided adjuvant therapy for liver cancer enters phase II
NCT07363356 is a planned 56-patient phase II trial that will use patient-derived hepatocellular carcinoma organoid drug sensitivity testing to select adjuvant therapy after curative resection, with recurrence-free survival as the primary endpoint.
August 25, 2026 A self-assembled human lung model captures IPF-like fibrosis and responds to pirfenidone
A hiPSC-derived multi-lineage lung organoid endogenously produces proximal airway-like, distal alveolar, fibroblast, endothelial and macrophage-like populations. TGF-beta1 drives ECM remodeling and ferroptosis-like mitochondrial changes that match human IPF transcriptomes, while pirfenidone reverses the fibrotic signature.
August 25, 2026 Live microtubule dynamics as a resistance readout in patient-derived organoids
A computer-vision platform tracks microtubule polymerization dynamics in living patient-derived cells and organoids, identifying parameters that correlate with resistance to paclitaxel and vinorelbine beyond their canonical tubulin-binding effects.
August 24, 2026 Aromatic hydrocarbons, AhR, and prostate organoids
A Frontiers review synthesizes mechanistic evidence that ambient aromatic hydrocarbons contribute to prostate cancer initiation and progression through AhR-AR crosstalk, CYP1A1/1B1 bioactivation, and immune suppression. The framework sets new requirements for environmental-exposure organoid models.
August 24, 2026 Parallel EMT programs and metastatic cell states
A TNBC organoid study argues that epithelial-mesenchymal plasticity generates multiple metastatic cell states through parallel ERK programs, not a single EMT endpoint. The finding reframes how tumor organoids should model metastatic competence.
August 24, 2026 SCN2A, cortical neurogenesis, and patient organoids
Isogenic and ASD patient-derived forebrain organoids link SCN2A sodium-channel loss to an excitatory-inhibitory neurogenesis imbalance via Sonic hedgehog signaling. The work suggests a developmental therapeutic window but not yet a clinical path.
August 23, 2026 Adrenomedullin rescues hypoxic interneuron migration in assembloids
Human forebrain assembloids and ex vivo fetal slices reveal that hypoxia stalls cortical interneuron migration, and that adrenomedullin signaling through RAMP2 restores saltations via the cAMP/PKA pathway.
August 23, 2026 Somitoid clock phase responses mapped at 384-well scale
A high-throughput hiPSC-derived somitoid assay maps segmentation clock phase responses to feeding perturbations, offering a scalable readout for developmental timing and teratogen screening.
August 23, 2026 IL-13 induces a CD45 checkpoint in intestinal tuft cells
A study in mice and intestinal organoids identifies CD45 as an epithelial checkpoint that restrains IL-13-driven tuft cell activation and limits type 2 immune responses to helminth infection.
August 22, 2026 Lung cancer organoid-immune co-cultures dissect ADC mechanism before the clinic
A prospective observational study combines HER2- and TROP2-positive non-small cell lung cancer organoids with autologous immune cells to measure ADC potency, payload internalization, and immune-mediated cytotoxicity.
August 22, 2026 Pancreatic organoid-on-a-chip aims to break the chemotherapy guessing game
A 164-patient multicenter registry in China is testing whether patient-derived pancreatic cancer organoids on chip can predict response to nab-paclitaxel-gemcitabine or FOLFIRINOX before treatment starts.
August 22, 2026 Perturb-seq in skin organoids exposes a biphasic NFKB2 differentiation switch
A single-cell CRISPR screen in epidermal organoids maps how transcription factors shape keratinocyte differentiation and uncovers a dual role for non-canonical NFKB2 signaling.
August 21, 2026 Blood vessel organoids trace IGFBP7-driven diabetic microangiopathy
A 7-day diabetic medium triggers pericyte loss and collagen-IV deposition in human blood vessel organoids. Proteomics point to IGFBP7 and downstream galectins, with supportive associations in UK Biobank and All of Us.
August 21, 2026 Cortical organoids reveal a conserved heat-stress signature
Heat stress suppresses ribosome biogenesis and metabolic genes across PBMCs, neurons, and cortical organoids. The cerebellum shows a distinct heatstroke signature, and Connectivity Map analysis nominates the mTOR inhibitor KU-0063794 as a potential reverser.
August 21, 2026 Pikali and Nocchu fusion promoters advance retinal organoid gene therapy
Pikali and Nocchu are fusion promoters that merge PR1.7 and GRK1 regulatory elements. In human retinal organoids they transduce 30-45% of photoreceptors, improving coverage over GRK1 and expression breadth over PR1.7.
August 20, 2026 ALDH marks hormone-sensitive stem cells in endometrial organoids
ALDH1A1-positive endometrial cells display organoid-forming capacity and hormone-dependent localization; ablation reduces glands. The work clarifies stem-cell identity but also shows how organoid assays can overstate clonogenic potential if the luminal-like fraction is ignored.
August 20, 2026 Aging lung epithelium loses organoid capacity through inflammaging
A bioRxiv preprint links lung epithelial aging to a pro-inflammatory secretome and WNT pathway repression that impair organoid formation. The finding reframes aged organoids as models of inflammaging but also warns that donor age can become a hidden variable in screens.
August 20, 2026 NGFR isolates salivary gland stem cells for organoid repair
NGFR identifies a conserved basal duct progenitor that builds salivary gland organoids and contributes to ductal-acinar regeneration after injury. The work advances regenerative models but rests on an immunodeficient, injury-heavy engraftment readout.
August 19, 2026 A prevention hypothesis missing its highest-risk genotype
Human intestinal organoids infected with coxsackievirus B1 show a common gut virus switching on the celiac-disease enzyme TG2 through interferon and JAK-STAT signaling, and an existing JAK inhibitor drug blocks it, but the organoids were never built from the HLA-DQ2/DQ8 genetic background the disease actually requires.
August 19, 2026 When a snapshot organoid stands in for a human test
Disrupting the histone gene H4C3 stunts skeletal growth and starves the mouse neocortex of new neurons, and a human cortical organoid shows the same gene switched on in the right cells. But every experiment that actually breaks the gene was done in mouse, not in the organoid.
August 19, 2026 The knockdown metric that hid an allele-selectivity failure
Patient-derived inner ear organoids let researchers watch antisense oligonucleotides reach hair cells and correct a splicing defect, but the same platform also showed that a headline 75 percent knockdown of a disease gene was hitting the healthy copy just as hard as the mutant one.